Biosafety and Health is a leading peer-reviewed journal published by ELSEVIER, dedicated to advancing knowledge and practice in the fields of biotechnology, infectious diseases, microbiology, and public health. With an ISSN of 2096-6962 and an E-ISSN of 2590-0536, this Open Access journal has been accessible to the global research community since 2019, fostering collaboration and innovation from its base in the Netherlands. Ranked Q2 in multiple categories according to the latest metrics, including Biotechnology and Microbiology (medical), it stands as a testament to high-quality, impactful research that influences clinical and environmental practices. The journal has achieved substantial recognition in various medical fields, ranking in the 88th percentile for Public Health, Environmental and Occupational Health, and the 78th percentile for Infectious Diseases. Researchers and practitioners seeking to contribute to this evolving domain are encouraged to submit their findings, as the journal aims to promote interdisciplinary dialogue and address pressing global health challenges.

The Journal of Epidemiology and Global Health (ISSN: 2210-6006; E-ISSN: 2210-6014), published by SpringerNature, stands as a premier open-access platform in the field of epidemiology, dedicated to advancing our understanding of global health challenges since 2011. Based in Switzerland, this journal is recognized for its significant contributions to the discipline, achieving an impressive Q1 ranking in Epidemiology and positioning itself at the 88th percentile within the Scopus Medicine - Epidemiology category. With a goal to disseminate innovative research and foster dialogue among scholars, public health professionals, and students, the journal provides a rich repository of empirical studies, reviews, and theoretical contributions that address pressing epidemiological issues. Its commitment to open access ensures that vital research is freely available to the global community, thereby amplifying its impact and relevance. Researchers seeking to publish and access high-quality, peer-reviewed articles will find the Journal of Epidemiology and Global Health an invaluable resource in navigating the ever-evolving landscape of public health.

One Health is a premier open-access journal published by Elsevier, dedicated to advancing the interconnected disciplines of Infectious Diseases and Public Health. Established in 2015, the journal aims to promote holistic approaches to health that consider the interactions between humans, animals, and the environment. With an impressive impact factor and recognition in the top quartiles of both Infectious Diseases and Public Health categories, One Health ranks highly within the Scopus database, showcasing its significant contribution to the field. Situated in the Netherlands, the journal encourages scholarly communication and collaboration, providing a vital platform for researchers, professionals, and students to disseminate their findings and strengthen global health initiatives. By utilizing the open access model, One Health ensures that critical research is freely available, fostering a broader understanding of health-related issues that span multiple sectors.

JOURNAL OF INFECTION is a premier academic publication in the fields of infectious diseases and medical microbiology, published by W B SAUNDERS CO LTD. With a profound impact factor and established since 1979, this journal serves as a crucial resource for researchers, clinicians, and policy-makers seeking to advance knowledge and understanding of infectious processes and their management. The JOURNAL OF INFECTION holds an impressive position in the academic hierarchy as reflected by its Q1 quartile rankings in both Infectious Diseases and Microbiology (medical) for 2023, further underscored by its Scopus rankings: #2 in Medical Microbiology and #5 in Medical Infectious Diseases, placing it in the 98th percentile overall. While the journal does not offer Open Access options, it provides a comprehensive outlet for innovative research, reviews, and clinical insights that drive the field forward. Published from the United Kingdom, it attracts a global readership keen on staying at the forefront of infectious disease research, making it an essential addition to any academic and clinical library.

Open Forum Infectious Diseases (ISSN: 2328-8957; E-ISSN: 2328-8957) is a leading open-access journal published by Oxford University Press, dedicated to advancing the field of infectious diseases. Since its inception in 2014, the journal has provided a platform for researchers to disseminate impactful findings in a rapidly evolving domain, achieving a remarkable Q1 ranking in both the Infectious Diseases and Oncology categories as of 2023. The journal encourages rigorous and innovative research, contributing significantly to global health discussions and informing best practices in clinical settings. As an open-access journal, it ensures that its content is accessible to a wide audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Positioned in the heart of the United States, Open Forum Infectious Diseases serves as a critical resource for the academic community, and its continued commitment to quality and relevance secures its status as an essential publication in the field.

New Microbes and New Infections is an esteemed peer-reviewed journal published by Elsevier Sci Ltd that has been a prominent platform for disseminating groundbreaking research in the fields of Infectious Diseases and Microbiology since its establishment in 2013. With an impressive Open Access model, this journal ensures that vital research findings are readily accessible to researchers, healthcare professionals, and academics worldwide. Positioned in the Q2 category for Infectious Diseases and Q3 for Microbiology in 2023, it reaches a significant global audience, as demonstrated by its high Scopus rankings—#44 out of 344 in Medicine: Infectious Diseases, and #34 out of 182 in Immunology and Microbiology. The journal aims to inspire new ideas and foster collaborations by publishing high-quality research focused on novel microbes and infections, thus playing a crucial role in advancing science and public health in an era where understanding infectious agents is more vital than ever.

VECTOR-BORNE AND ZOONOTIC DISEASES is a prominent journal dedicated to advancing research in the fields of infectious diseases, microbiology, and virology, published by Mary Ann Liebert, Inc. With a rich history spanning from 2001 to 2024, this journal plays a critical role in disseminating cutting-edge research and insights regarding diseases transmitted by vectors and zoonotic pathogens. It has achieved notable rankings, including Q2 in the Infectious Diseases category and Q3 in both Microbiology and Virology as of 2023. The journal's emphasis on quality and relevance is further underscored by its established position—ranked 151st in Infectious Diseases and within the 43rd percentile in Virology according to Scopus. Although not an open-access journal, the publication ensures that its findings reach a broad audience of researchers, professionals, and students dedicated to tackling the challenges posed by these critical health issues. By providing a platform for innovative studies and discussions, VECTOR-BORNE AND ZOONOTIC DISEASES remains an essential resource for those at the forefront of disease research and public health strategies.

Journal of Infection in Developing Countries, published by J INFECTION DEVELOPING COUNTRIES, is a premier open-access journal dedicated to advancing research in the fields of infectious diseases, microbiology, parasitology, and virology, particularly within the context of developing nations. Established in 2007 and actively disseminating knowledge since 2008, this journal aims to bridge the gap between researchers and practitioners by providing a platform for high-quality, peer-reviewed articles that address the unique challenges faced in these regions. With an ISSN of 1972-2680 and a robust HIndex showcasing its growing influence, JIDC has attained a Q3 category ranking in several disciplines as of 2023, indicating its crucial role in shaping ongoing discourse in public health. As an open-access publication, it ensures that vital research is accessible to all, fostering collaboration and innovation in infectious disease management and control.

Southern African Journal of Infectious Diseases is a pivotal platform for the dissemination and advancement of research in the field of infectious diseases, with a particular focus on issues significant to the Southern African region. Published by AOSIS, this Open Access journal has been committed to providing accessible scholarly content since 2016, enabling researchers and practitioners to stay updated with the latest developments in infectious disease epidemiology, prevention, and management. With the ISSN 2312-0053 and E-ISSN 2313-1810, the journal invites submissions that explore diverse topics, including but not limited to clinical studies, public health policies, and innovative treatment methodologies. The Southern African Journal of Infectious Diseases is an essential resource for academics, professionals, and students dedicated to combating infectious diseases and improving health outcomes in the region, fostering a collaborative approach to research and knowledge sharing.

The American Journal of Tropical Medicine and Hygiene, published by the American Society of Tropical Medicine & Hygiene, serves as a pivotal platform for the dissemination of innovative research and clinical findings in the realm of tropical medicine and health. With an illustrious history dating back to 1945, this journal has maintained its commitment to enhancing global health, particularly in the fields of Infectious Diseases, Parasitology, and Virology. It currently boasts an impressive impact factor and ranks in the Q1 category for Parasitology and Q2 for Infectious Diseases and Medicine (miscellaneous), highlighting its academic prominence. The journal's mission is to advance research, showcase cutting-edge studies, and foster collaboration among researchers, healthcare professionals, and students dedicated to tackling tropical diseases and improving public health worldwide. While access is not open, the journal remains a critical resource for anyone looking to stay informed on the latest advancements in the field.